{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:46:17Z","timestamp":1793724377097,"version":"4.6.1"},"reference-count":39,"publisher":"European Respiratory Society (ERS)","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["Mobilise-D project 820820"],"award-info":[{"award-number":["Mobilise-D project 820820"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2023,7,31]]},"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec><jats:title>Rationale<\/jats:title><jats:p>The effect of pharmacological and non-pharmacological interventions on physical activity (PA) outcomes is not fully elucidated in patients with COPD. The objectives of the present study were to provide estimation of treatment effects of all available interventions on PA outcomes in patients with COPD and to provide recommendations regarding the future role of PA outcomes in pharmacological trials.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>This review was conducted according to the Cochrane Handbook for Systematic Reviews of Interventions and reported in line with PRISMA. Records were identified through searches of 12 scientific databases; the most updated search was performed in January 2023.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>74 studies published from 2000 to 2021 were included, with a total of 8140 COPD patients. Forced expiratory volume in 1\u2005s % predicted ranged between 31% and 74%, with a mean of 55%. Steps\/day constituted the most frequently assessed PA outcome in interventional studies. Compared to usual care, PA behavioural modification interventions resulted in improvements in the mean (95% CI) steps\/day when implemented alone (by 1035 (576\u20131493); p&lt;0.00001) or alongside exercise training (by 679 (93\u20131266); p=0.02). Moreover, bronchodilator therapy yielded a favourable difference of 396 (125\u2013668; p=0.004) steps\/day, compared to placebo.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>PA behavioural modification and pharmacological interventions lead to significant improvements in steps\/day, compared to control and placebo groups, respectively. Compared to bronchodilator therapy, PA behavioural modification interventions were associated with a 2-fold greater improvement in steps\/day. Large-scale pharmacological studies are needed to establish an intervention-specific minimal clinically important difference for PA outcomes as well as their convergent validity to accelerate qualification as potential biomarkers and efficacy end-points for regulatory approval.<\/jats:p><\/jats:sec>","DOI":"10.1183\/23120541.00409-2023","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T15:30:23Z","timestamp":1694100623000},"page":"00409-2023","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Effects of pharmacological and non-pharmacological interventions on physical activity outcomes in COPD: a systematic review and meta-analysis"],"prefix":"10.1183","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6786-4346","authenticated-orcid":false,"given":"Dimitrios","family":"Megaritis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0462-2395","authenticated-orcid":false,"given":"Emily","family":"Hume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9595-6974","authenticated-orcid":false,"given":"Nikolaos","family":"Chynkiamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1383-2485","authenticated-orcid":false,"given":"Christopher","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5056-5785","authenticated-orcid":false,"given":"Ashley M.","family":"Polhemus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1506-2661","authenticated-orcid":false,"given":"Henrik","family":"Watz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2767-5027","authenticated-orcid":false,"given":"Thierry","family":"Troosters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4830-7207","authenticated-orcid":false,"given":"Ioannis","family":"Vogiatzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2023,9,7]]},"reference":[{"key":"2024101712050420000_9.5.00409-2023.1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2013-204763"},{"key":"2024101712050420000_9.5.00409-2023.2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00023214"},{"key":"2024101712050420000_9.5.00409-2023.3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200408-1054OC"},{"key":"2024101712050420000_9.5.00409-2023.4","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.3.536"},{"key":"2024101712050420000_9.5.00409-2023.5","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-2521"},{"key":"2024101712050420000_9.5.00409-2023.6","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2014"},{"key":"2024101712050420000_9.5.00409-2023.7","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201309-1634ST"},{"key":"2024101712050420000_9.5.00409-2023.8","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2006.060145"},{"key":"2024101712050420000_9.5.00409-2023.9","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00046814"},{"key":"2024101712050420000_9.5.00409-2023.10","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.chest.2021.06.044","article-title":"Objectively measured physical activity as a COPD clinical trial outcome","volume":"160","author":"Burtin","year":"2021","journal-title":"Chest"},{"key":"2024101712050420000_9.5.00409-2023.11","first-page":"CD012626","article-title":"Interventions for promoting physical activity in people with chronic obstructive pulmonary disease (COPD)","volume":"4","author":"Burge","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2024101712050420000_9.5.00409-2023.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60735-1"},{"key":"2024101712050420000_9.5.00409-2023.13","first-page":"528","article-title":"Objectively measured physical activity in patients with COPD: recommendations from an international task force on physical activity","volume":"8","author":"Demeyer","year":"2021","journal-title":"Chronic Obstr Pulm Dis"},{"key":"2024101712050420000_9.5.00409-2023.14","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2022.557"},{"key":"2024101712050420000_9.5.00409-2023.15","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2022-BTSabstracts.305"},{"key":"2024101712050420000_9.5.00409-2023.16","unstructured":"Higgins J , Thomas J , Chandler J , et al. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.2. Date last updated: February 2021. Date last accessed: 1 June 2023. www.training.cochrane.org\/handbook"},{"key":"2024101712050420000_9.5.00409-2023.17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"2024101712050420000_9.5.00409-2023.18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41746-021-00513-5","article-title":"Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomes","volume":"4","author":"Polhemus","year":"2021","journal-title":"NPJ Digit Med"},{"key":"2024101712050420000_9.5.00409-2023.19","doi-asserted-by":"publisher","DOI":"10.1093\/ptj\/83.8.713"},{"key":"2024101712050420000_9.5.00409-2023.20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2288-14-30","article-title":"Which is more generalizable, powerful and interpretable in meta-analyses, mean difference or standardized mean difference?","volume":"14","author":"Takeshima","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"2024101712050420000_9.5.00409-2023.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphys.2019.08.005"},{"key":"2024101712050420000_9.5.00409-2023.22","doi-asserted-by":"publisher","DOI":"10.1097\/XEB.0000000000000065"},{"key":"2024101712050420000_9.5.00409-2023.23","unstructured":"Locke EA , Latham GP. A Theory of Goal Setting and Task Performance. Englewood Cliffs, Prentice-Hall Inc, 1990."},{"key":"2024101712050420000_9.5.00409-2023.24","unstructured":"Miller WR , Rollnick S . Motivational Interviewing: Helping People Change. 3rd Edn. New York, Guilford Press, 2013."},{"key":"2024101712050420000_9.5.00409-2023.25","first-page":"e4985","article-title":"Global Initiative for Chronic Obstructive Lung Disease: the changes made","volume":"11","author":"Patel","year":"2019","journal-title":"Cureus"},{"key":"2024101712050420000_9.5.00409-2023.26","doi-asserted-by":"publisher","DOI":"10.1139\/apnm-2012-0235"},{"key":"2024101712050420000_9.5.00409-2023.27","doi-asserted-by":"crossref","first-page":"afab242","DOI":"10.1093\/ageing\/afab242","article-title":"Mobility endpoints in marketing authorisation of drugs: what gets the European Medicines Agency moving?","volume":"51","author":"Jaeger","year":"2022","journal-title":"Age Ageing"},{"key":"2024101712050420000_9.5.00409-2023.28","doi-asserted-by":"crossref","first-page":"996903","DOI":"10.3389\/fmed.2022.996903","article-title":"On the use of wearable sensors as mobility biomarkers in the marketing authorization of new drugs: a regulatory perspective","volume":"9","author":"Viceconti","year":"2022","journal-title":"Front Med"},{"key":"2024101712050420000_9.5.00409-2023.29","doi-asserted-by":"crossref","first-page":"1479973118816424","DOI":"10.1177\/1479973118816424","article-title":"Physical activity in COPD: minimal clinically important difference for medical events","volume":"16","author":"Teylan","year":"2019","journal-title":"Chron Respir Dis"},{"key":"2024101712050420000_9.5.00409-2023.30","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201701-0218PP"},{"key":"2024101712050420000_9.5.00409-2023.31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1164\/rccm.202006-2618OC","article-title":"Reduced all-cause mortality in the ETHOS trial of budesonide\/glycopyrrolate\/formoterol for chronic obstructive pulmonary disease. A randomized, double-blind, multicenter, parallel-group study","volume":"203","author":"Martinez","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101712050420000_9.5.00409-2023.32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154587"},{"key":"2024101712050420000_9.5.00409-2023.33","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-14-115"},{"key":"2024101712050420000_9.5.00409-2023.34","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201505-0929CI"},{"key":"2024101712050420000_9.5.00409-2023.35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1164\/rccm.201706-1316LE","article-title":"Are all steps created equal? Revisiting pedometer use during pulmonary rehabilitation for individuals living with chronic obstructive pulmonary disease","volume":"197","author":"Sasso","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101712050420000_9.5.00409-2023.36","doi-asserted-by":"crossref","unstructured":"Krabbe PFM . Validity. In: Krabbe PFM , ed. The Measurement of Health and Health Status. San Diego, Academic Press, 2017; pp. 113\u2013134.","DOI":"10.1016\/B978-0-12-801504-9.00007-6"},{"key":"2024101712050420000_9.5.00409-2023.37","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1164\/rccm.202003-0625ST","article-title":"Pharmacologic management of chronic obstructive pulmonary disease. An official American Thoracic Society clinical practice guideline","volume":"201","author":"Nici","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101712050420000_9.5.00409-2023.38","doi-asserted-by":"publisher","DOI":"10.3109\/15412555.2012.752807"},{"key":"2024101712050420000_9.5.00409-2023.39","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2021-218360"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00409-2023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:29:51Z","timestamp":1740374991000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00409-2023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,9,25]]},"published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1183\/23120541.00409-2023"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00409-2023","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}